Skip to main navigation

Search for:

Search

Rubius Therapeutics

About Us
Our Science
Our Pipeline
Investors & Media
Careers
Contact

Menu Search

Press Releases

Year

November 14, 2019

Rubius Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress

November 12, 2019

Rubius Therapeutics to Participate in Jefferies London Healthcare Conference

November 12, 2019

Rubius Therapeutics Appoints Maiken Keson-Brookes as Chief Legal Officer and Corporate Secretary

November 8, 2019

Rubius Therapeutics Highlights Preclinical Oncology Data at Society for Immunotherapy of Cancer Annual Meeting and AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

November 5, 2019

Rubius Therapeutics to Announce Third Quarter 2019 Financial Results

October 17, 2019

Rubius Therapeutics Announces Oncology Poster Presentations at Upcoming Medical Conferences

September 3, 2019

Rubius Therapeutics to Participate in 17th Annual Morgan Stanley Global Healthcare Conference

August 13, 2019

Rubius Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress

August 7, 2019

Rubius Therapeutics to Announce Second Quarter 2019 Financial Results

July 25, 2019

Rubius Therapeutics Appoints Kris Elverum as Senior Vice President of Business Development and Strategy

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 23

Print Page

RSS Feeds

Share Page

Email Alerts

Contact Us

399 Binney St, Suite 300
Cambridge, MA 02139 617-679-9600

Share

LinkedIn Twitter

Home
About Us
Our Science
Our Pipeline
Investors
Careers
Sitemap
Terms of Use
Privacy Policy

© Rubius Therapeutics, Inc. 2019. All Rights Reserved. RUBIUS and RED PLATFORM are registered trademarks of Rubius Therapeutics, Inc. RUBIUS THERAPEUTICS, RED CELL THERAPEUTICS and RCT are trademarks of Rubius Therapeutics, Inc. All other trademarks referenced herein are the properties of their respective owners.

Facebook
Twitter
LinkedIn